PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Operating margin 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) operating margin by fiscal year — reported operating income divided by reported revenue.
-1575.3%FY2025 · since FY2022: -346.6% → -1575.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1575.3% | -840.9 pp |
| FY2024 | -734.4% | -214.2 pp |
| FY2023 | -520.2% | -173.6 pp |
| FY2022 | -346.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice